Family Medicine · Louisville, KY
NPI
1003922923
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1169 Eastern Pkwy Ste 2265
Louisville, KY, 40217
Phone (502) 635-7455
Groups this clinician bills Medicare through
Medicare paid, 2024
$242K
22,282 services
Medicare patients, 2024
784
Average age 74
Drug cost, 2024
$2.0M
21,732 prescriptions
Company payments, 2025
$850
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John L Markert was code J1010 (injection, methylprednisolone acetate, 1 mg), 5,981 times for 69 patients. In total John L Markert billed 22,282 services in 54 codes, and Medicare paid $242K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 5,981 | 69 | $0.09 | $552 |
| 36415 Venipuncture Blood Collection | Office | 1,457 | 734 | $8.60 | $13K |
| 99214 Office E&M - Established | Office | 1,006 | 571 | $74.13 | $75K |
| 99213 Office E&M - Established | Office | 896 | 589 | $48.60 | $44K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 597 | 597 | $120.46 | $72K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 319 | 263 | $9.15 | $2,919 |
| 96372 Injection Administration | Office | 224 | 111 | $8.74 | $1,957 |
| 81003 Clinical Chemistry | Office | 156 | 103 | $2.19 | $341 |
| 99211 Office E&M - Established | Office | 107 | 51 | $14.10 | $1,509 |
| 87426 Immunoassay | Office | 81 | 73 | $32.91 | $2,666 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 69 | 13 | $0.84 | $57.86 |
| 85610 Clinical Chemistry | Office | 66 | 14 | $4.20 | $277 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 45 | 33 | $37.16 | $1,672 |
| 99215 Office E&M - Established | Office | 41 | 35 | $121.48 | $4,981 |
| 93000 Electrocardiogram | Office | 39 | 38 | $7.80 | $304 |
By year: 2022 $183K for 5,655 services; 2023 $222K for 11,264 services; 2024 $242K for 22,282 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,457 | 734 | $8.60 | $13K |
| 81003 Clinical Chemistry | 156 | 103 | $2.19 | $341 |
| 87426 Immunoassay | 81 | 73 | $32.91 | $2,666 |
| 85610 Clinical Chemistry | 66 | 14 | $4.20 | $277 |
| 87804 Immunoassay | 31 | 28 | $15.70 | $487 |
| 87880 Immunoassay | 16 | 15 | $15.19 | $243 |
Medicare prescription drug claims, 2024
In 2024, the drug John L Markert prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,054 prescriptions and refills. In total John L Markert wrote 21,732 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,054 | 3,019 | 286 | $8,172 |
| Rosuvastatin Calcium Generic | 861 | 2,496 | 260 | $9,284 |
| Lisinopril Generic | 836 | 2,337 | 230 | $4,289 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 700 | 700 | 108 | $13K |
| Gabapentin Generic | 655 | 817 | 111 | $7,738 |
| Amlodipine Besylate Generic | 651 | 1,886 | 184 | $2,835 |
| Alprazolam Generic | 500 | 500 | 73 | $2,488 |
| Metformin Hcl Generic | 435 | 1,212 | 129 | $2,115 |
| Zolpidem Tartrate Generic | 435 | 451 | 59 | $1,743 |
| Pantoprazole Sodium Generic | 422 | 1,170 | 130 | $6,014 |
| Metoprolol Succinate Generic | 421 | 1,207 | 122 | $6,156 |
| Furosemide Generic | 418 | 1,063 | 129 | $1,703 |
| Levothyroxine Sodium Generic | 362 | 1,005 | 96 | $3,794 |
| Lorazepam Generic | 359 | 361 | 61 | $1,477 |
| Losartan Potassium Generic | 332 | 966 | 93 | $2,762 |
Brand drugs: 2,516 claims; generic drugs: 19,039 claims; opioid claims: 1,300.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John L Markert $850 ($850 in general payments such as food, travel and fees) from 16 companies. The largest payer was Novo Nordisk Inc with $233.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 9 | $233 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $210 |
| Pfizer Inc. PFE | 5 | $86.39 |
| Lilly USA, LLC LLY | 3 | $55.08 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $37.98 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $32.89 |
| Abbvie Inc. ABBV | 2 | $31.74 |
| Merck Sharp & Dohme LLC MRK | 1 | $25.71 |
| Tolmar, Inc. | 1 | $21.11 |
| Exact Sciences Corporation EXAS | 1 | $19.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.